Menstrual Cycle Characteristics and Incidence of Premenopausal Breast Cancer
Open Access
- 1 June 2005
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (6) , 1509-1513
Abstract
Background: Epidemiologic studies have indicated that menstrual cycle characteristics such as age at menarche and age at menopause are associated with breast cancer risk. Anovulation, which is more common with long or irregular cycles, has been hypothesized to reduce the incidence of breast cancer. Methods: We analyzed data from the Nurses' Health Study II, a cohort of 116,671 female registered nurses ages 25 to 42 years at baseline. Information on menstrual cycle characteristics was assessed in 1989 and 1993, and incident cases of premenopausal breast cancer were ascertained through 2001. Results: During 1,135,496 person-years of follow-up (1989-2001), 1,163 incident cases of invasive premenopausal breast cancer were diagnosed. Overall, women with long menstrual cycles at ages 18 to 22 years (>32 days or too irregular to estimate) did not experience a significantly lower breast cancer risk compared with women with normal cycle lengths (26-31 days) at that age [covariate-adjusted hazard ratio (HR), 0.92; 95% confidence interval (95% CI), 0.79-1.06]. Among women ages 32 days or too irregular to estimate at ages 18 to 22 years had a decreased incidence of breast cancer (covariate-adjusted HR, 0.71; 95% CI, 0.53-0.97). Current menstrual cycle characteristics were not associated with breast cancer incidence. Conclusion: Overall, longer or irregular cycles at ages 18 to 22 years or in early adulthood were not associated with reduced premenopausal breast cancer risk. However, longer menstrual cycles at ages 18 to 22 years were associated with a lower incidence of premenopausal breast cancer before age 40.Keywords
This publication has 25 references indexed in Scilit:
- Type 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses’ Health StudyDiabetes Care, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer studyInternational Journal of Cancer, 2000
- Menstrual factors in relation to breast cancer risk.1998
- Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-upJournal of Clinical Epidemiology, 1998
- Regularity and length of menstrual cycles in women aged 41–46 in relation to breast cancer risk: Results from the DOM-projectBreast Cancer Research and Treatment, 1996
- The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal WomenNew England Journal of Medicine, 1995
- Lifelong Menstrual Pattern and Risk of Breast CancerOncology, 1993
- Menstrual cycle patterns and the risk of breast diseaseEuropean Journal of Cancer and Clinical Oncology, 1985
- Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidineHuman Pathology, 1977